Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RAB | RABIES (RABAVERT) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | Unknown | — |
The patient received only diluent of RabAvert; The patient received only diluent of RabAvert; Case reference number US-BN-2024-002121 is a spontaneous case initially received from pharmacist via Med Communications (reference number USBAV24-1545) on 01-Jul-2024 and concerns a patient of unspecified age and gender. The patient's medical history and concomitant medication details were not provided. On an unspecified date, the patient was vaccinated with only a diluent of RabAvert (batch number: unknown), at an unknown dose, route, and site of administration, for unknown indication (explicitly coded as 'product administration error' and 'active ingredient not added to diluent'). As reported, the reporter wanted to know how long the powder goof would for at room temperature. At the time of the initial report, it was unknown if the patient experienced an adverse event due to RabAvert. No further information was provided.; Reporter's Comments: A patient of unspecified age and gender was vaccinated with only a diluent of RabAvert, at an unknown dose, route, and site of administration, for unknown indication which is considered as product administration error and 'active ingredient not added to diluent. Product administration error and product preparation error are both considered listed per company conventions. At this point, it was unknown if the patient experienced an adverse event due to RabAvert. The patient's medical history and concomitant medication details were not provided. Product administration error and product preparation error are both assessed as not related to suspect product but to human factor. The case is non-serious.; Sender's Comments: A patient of unspecified age and gender was vaccinated with only a diluent of RabAvert, at an unknown dose, route, and site of administration, for unknown indication which is considered as product administration error and 'active ingredient not added to diluent. Product administration error and product preparation error are both considered listed per company conventions. At this point, it was unknown if the patient experienced an adverse event due to RabAvert. The patient's medical history and concomitant medication details were not provided. Product administration error and product preparation error are both assessed as not related to suspect product but to human factor. The case is non-serious. USBAV24-1545:
Comments: None